Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |